Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
May 31, 2026
Classic psychedelics and personality: An updated systematic review
Anna Beatriz Vicentini, Caio César de Paula, José Augusto Silva Reis, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 13, 2006
Cannabidiol monotherapy for treatment-resistant schizophrenia
Antonio Waldo Zuardi, Jaime E C Hallak, Serdar Murat Dursun, et al.
Frontiers in Pharmacology
|
May 30, 2017
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W Zuardi, Natália P Rodrigues, Angélica L Silva, et al.
Drug and Alcohol Review
|
December 1, 2022
Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences
Borja J Rodríguez-Cano, Maja Kohek, Genís Ona, et al.
Frontiers in Pharmacology
|
July 10, 2025
Ketogenic therapy for schizophrenia: evidence, mechanisms, and clinical perspectives
Cristiano Chaves, Jennifer Fabe, Fabiano A Gomes, et al.
Psychopharmacology
|
October 29, 2020
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
Richard J Zeifman, Nikhita Singhal, Rafael G Dos Santos, et al.
Toxicology and Applied Pharmacology
|
April 5, 2026
Early-life exposure to Cannabidiol: Safety assessment of a chronic exposure in Caenorhabditis elegans
Heloísa Aiolfi Padilha, Jean Freitas Reginatto, Júlia Dorneles Saleh, et al.
Talanta
|
February 17, 2021
Essential oil-based dispersive liquid-liquid microextraction for the determination of N,N-dimethyltryptamine and β-carbolines in human plasma: A novel solvent-free alternative
Gabriela de Oliveira Silveira, Felipe Rebello Lourenço, Ana Miguel Fonseca Pego, et al.
Current Pharmaceutical Design
|
June 22, 2012
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
Antonio Waldo Zuardi, Jose Alexandre S Crippa, Jaime E C Hallak, et al.
Scientific Reports
|
March 7, 2020
Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination
Daniel F Jiménez-Garrido, María Gómez-Sousa, Genís Ona, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
Journal of Psychopharmacology (Oxford, England)
|
May 31, 2026
Classic psychedelics and personality: An updated systematic review
Anna Beatriz Vicentini, Caio César de Paula, José Augusto Silva Reis, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 13, 2006
Cannabidiol monotherapy for treatment-resistant schizophrenia
Antonio Waldo Zuardi, Jaime E C Hallak, Serdar Murat Dursun, et al.
Frontiers in Pharmacology
|
May 30, 2017
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W Zuardi, Natália P Rodrigues, Angélica L Silva, et al.
Drug and Alcohol Review
|
December 1, 2022
Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences
Borja J Rodríguez-Cano, Maja Kohek, Genís Ona, et al.
Frontiers in Pharmacology
|
July 10, 2025
Ketogenic therapy for schizophrenia: evidence, mechanisms, and clinical perspectives
Cristiano Chaves, Jennifer Fabe, Fabiano A Gomes, et al.
Psychopharmacology
|
October 29, 2020
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
Richard J Zeifman, Nikhita Singhal, Rafael G Dos Santos, et al.
Toxicology and Applied Pharmacology
|
April 5, 2026
Early-life exposure to Cannabidiol: Safety assessment of a chronic exposure in Caenorhabditis elegans
Heloísa Aiolfi Padilha, Jean Freitas Reginatto, Júlia Dorneles Saleh, et al.
Talanta
|
February 17, 2021
Essential oil-based dispersive liquid-liquid microextraction for the determination of N,N-dimethyltryptamine and β-carbolines in human plasma: A novel solvent-free alternative
Gabriela de Oliveira Silveira, Felipe Rebello Lourenço, Ana Miguel Fonseca Pego, et al.
Current Pharmaceutical Design
|
June 22, 2012
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
Antonio Waldo Zuardi, Jose Alexandre S Crippa, Jaime E C Hallak, et al.
Scientific Reports
|
March 7, 2020
Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination
Daniel F Jiménez-Garrido, María Gómez-Sousa, Genís Ona, et al.
Page
of 13